Adverse Events and Safety Outcomes Associated With Chemotherapy for Inflammatory Bowel Disease–associated Gastrointestinal Cancers
Anticancer Research · 2026
DOI: 10.21873/anticanres.18098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Noboru Hasegawa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Osaka, Japan. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Inflammatory Bowel Diseases, Antineoplastic Combined Chemotherapy Protocols, Crohn Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Patientensicherheit, Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
- Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Osaka, Japan togino04@gesurg.med.osaka-u.ac.jp.
Zitieren
APA
Hasegawa, N., Ogino, T., Sekido, Y., Takeda, M., Hata, T., Hamabe, A., Miyoshi, N., Uemura, M., Eguchi, H., & Doki, Y. (2026). Adverse Events and Safety Outcomes Associated With Chemotherapy for Inflammatory Bowel Disease–associated Gastrointestinal Cancers. Anticancer Research. https://doi.org/10.21873/anticanres.18098
Vancouver
Hasegawa N, Ogino T, Sekido Y, Takeda M, Hata T, Hamabe A, et al. Adverse Events and Safety Outcomes Associated With Chemotherapy for Inflammatory Bowel Disease–associated Gastrointestinal Cancers. Anticancer Research. 2026. doi:10.21873/anticanres.18098
BibTeX
@article{Hasegawa2026,
author = {Hasegawa, Noboru and Ogino, Takayuki and Sekido, Yuki and Takeda, Mitsunobu and Hata, Tsuyoshi and Hamabe, Atsushi and Miyoshi, Norikatsu and Uemura, Mamoru and Eguchi, Hidetoshi and Doki, Yuichiro},
title = {Adverse Events and Safety Outcomes Associated With Chemotherapy for Inflammatory Bowel Disease–associated Gastrointestinal Cancers},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18098}
}
EUVIMED